本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Solid Biosciences

7.00
+0.32004.79%
盤後6.98-0.0201-0.29%19:55 EDT
成交量:151.58萬
成交額:1,026.34萬
市值:5.43億
市盈率:-2.40
高:7.00
開:6.70
低:6.47
收:6.68
資料載入中...
2024/11/14

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/01

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/02

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/12

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/11

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/11

重要事件披露

Form 8-K - Current report
2024/06/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/15

SEC問詢函

Form CORRESP - Correspondence
2024/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/07

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

SEC問詢函

Form CORRESP - Correspondence